| Literature DB >> 32813566 |
Juan Carlos García-Betancur1, Tobias Manuel Appel1, German Esparza2, Ana C Gales3, Gabriel Levy-Hara4, Wanda Cornistein5, Silvio Vega6, Duilio Nuñez7, Luis Cuellar8, Luis Bavestrello9, Paulo F Castañeda-Méndez10, Juan M Villalobos-Vindas11, María Virginia Villegas1,12.
Abstract
INTRODUCTION: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. AREAS COVERED: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. EXPERT OPINION: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.Entities:
Keywords: Acinetobacter baumannii ; Klebsiella pneumoniae ; Pseudomonas aeruginosa ; Latin America; carbapenem resistance; carbapenem-resistant Enterobacterales (CRE); carbapenemases; carbapenems
Year: 2020 PMID: 32813566 DOI: 10.1080/14787210.2020.1813023
Source DB: PubMed Journal: Expert Rev Anti Infect Ther ISSN: 1478-7210 Impact factor: 5.091